Milliman Risk Score 2.0: stratifying mortality risk using prescription drug information


Our colleagues at Munich Re Life US assessed the effectiveness of the Milliman Rx Risk Score 2.0, a predictive modeling tool developed and owned by Milliman that assesses mortality risk using an individual’s prescription drug information. Our findings demonstrated that the enhanced Rx Risk Score 2.0 is indeed predictive of mortality for the U.S. insurance applicant population.


We use cookies on our websites to improve your experience as an internet user, and to optimise our online services. They comprise cookies that are required for technical purposes, and without which the website functionality could not be guaranteed. We also employ cookies to carry out statistical evaluations of the reach of our websites. These evaluations are anonymised. You can find further information on the cookies we use, and ways to object to the use of cookies for statistical evaluations, in our cookie guidelines.